Cancer Misdiagnosed in 12% of Cases: Study by Alan Mozes

According to Alan Mozes’ report, Monday October 10 in Health Day Reporter, a new study suggests more than 12 percent of cancer patients in the U.S. are undiagnosed initially. Apparently this leads to treatment delays and lost opportunities for better outcomes.

The study was conducted by a team of researchers from Canada, China and the United States but based upon the experience of four American medical centers.

Study author Dr. Stephen S. Raab, a professor of pathology at the University of Pittsburgh School of Medicine said “I want to make clear that the major consequence is not that patients unnecessarily have organs removed or have a false diagnosis of cancer, but rather that they have cancer and it is not diagnosed.”

This study provides insight concerning the accuracy of cancer diagnosis nationwide. The researchers estimate by extrapolation that about 150,000 cancer patients who undergo Pap tests annually may be subject to such mistakes. If the probability of error in cancer testing applies, as these researchers suspect, across the broad spectrum of cancer diagnosis, then surely many patients needlessly suffer from delay.

All articles in this blog are the collaborative effort of Lupetin & Unatin, LLC.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

What can we help you find?

During these unusual circumstances concerning the coronavirus, we are working to respond as quickly as possible to your phone calls and emails. You can expect to hear back from us within 24 hours or one business day (Monday – Friday).